Prodigiosin Induces Apoptosis by Acting on Mitochondria in Human Lung Cancer Cells
- 1 December 2003
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1010 (1) , 178-181
- https://doi.org/10.1196/annals.1299.030
Abstract
Abstract: Prodigiosin (PG) is a secondary metabolite, isolated from a culture of Serratia marcescens, which has shown potent cytotoxicity against various human cancer cell lines as well as immunosuppressive activity. The purpose of this study was to evaluate the role of mitochondria in PG‐induced apoptosis. Therefore, we evaluated the apoptotic action of PG in GLC4 small cell lung cancer cell line by Hoechst 33342 staining. In these cells, we examined mitochondrial apoptosis‐inducing factor (AIF) and cytochrome c (cyt c) release to the cytosol in PG time‐response studies. These findings suggest that PG induces apoptosis in both caspase‐dependent and caspase‐independent pathways.Keywords
This publication has 6 references indexed in Scilit:
- Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemiaLeukemia, 2003
- Prodigiosin Induces Caspase‐9 and Caspase‐8 Activation and Cytochrome C Release in Jurkat T CellsAnnals of the New York Academy of Sciences, 2002
- Prodigiosin-induced apoptosis in human colon cancer cellsLife Sciences, 2001
- Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell linesBritish Journal of Pharmacology, 2000
- Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell deathCell Death & Differentiation, 1999